Drug company raised opioid treatment price by 600 percent to capitalize on crisis, says new report from Sen. Rob Portman

[RSS]

Drug company raised opioid treatment price by 600 percent to capitalize on crisis, says new report from Sen. Rob Portman

A Virginia pharmaceutical company raised the price of its opioid overdose reversal drug by more than 600 percent in 2016 as a way to "capitalize on the opportunity" of the  epidemic of overdoses, says a report released Sunday by an investigative subcommittee chaired by Ohio GOP Sen. Rob. Portman.





A Virginia pharmaceutical company raised the price of its opioid overdose reversal drug by more than 600 percent in 2016 as a way to "capitalize on the opportunity" of the  epidemic of overdoses, says a report released Sunday by an investigative subcommittee chaired by Ohio GOP Sen. Rob. Portman.

Source: Drug company raised opioid treatment price by 600 percent to capitalize on crisis, says new report from Sen. Rob Portman